Human papilloma virus (HPV) is a viral agent whose transmission occurs mainly by sexual
means. It causes different pathological conditions in both males and females, ranging from …

Cancer represents a significant cause of death and suffering in both the developed and
developing countries. Key underlying issues in the mortality of cancer are delayed diagnosis …

Background A bivalent human papillomavirus vaccine (2vHPV) is currently used in the
Netherlands; a nonavalent vaccine (9vHPV) is also licensed. Research design and methods …

The World Health Organization (WHO) set the goal of 90% HPV vaccination coverage in the
population to eliminate cervical cancer. Opportunistic vaccination is performed outside the …

Background: In many advanced countries other than Japan, the incidence and mortality
rates of cervical cancer, which is mainly caused by the human papillomavirus (HPV) …

Human papillomavirus (HPV) infection is associated with precancerous lesions and cancer
of the genital tract both in women and men. The high incidence of cervical cancer worldwide …

Background: The vaccination coverage of a population is the usual indicator of the
effectiveness of vaccination strategies. The study aims to evaluate the effectiveness of an …

Background and purpose: Human papillomavirus (HPV) often infects humans through
sexual contact. Men are carriers of the HPV virus and inadvertently transmit the virus to their …

Abstract Vaccination against Human Papilloma Virus continues to remain a highly complex
public health issue, as there are many countries or regions that show increasing reluctance …

Human papilloma virus (HPV) is a viral agent whose transmission occurs mainly by sexual
means. It causes different pathological conditions in both males and females, ranging from …